Status:

UNKNOWN

Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients

Lead Sponsor:

Samsung Medical Center

Conditions:

Depression

Adverse Reaction to Drug

Eligibility:

All Genders

19-89 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether pharmacogenomic study predict antidepressant responsiveness in advance before the appearance of the drug effects until 4\~6 weeks after drug administr...

Detailed Description

The purpose of this study is 1. to determine whether genomic effects on antidepressant response differed by class of drug, 2. whether genomic differences between drug responders and nonresponders pre...

Eligibility Criteria

Inclusion

  • Eligible patients were enrolled in the clinical trials program of hte Samsung Medical Center Geropsychiatry and Affective Disorder Clinics(Seoul, Korea). They received a semistructured diagnostic interview, the Samsung Psychiatric Evaluation Schedule. The affective disorder section of the Samsung Psychiatric Evaluation Schedule uses the Korean version of the structured clinical interview for the diagnostic and statistical manual of mental disorders, Fourth edition.
  • interview with one more patient's family member for objective diagnosis and final diagnosis decision by agreements of two more psychiatric physicians

Exclusion

  • received psychotropic medication within 2 weeks of the study or fluoxetine within 4 weeks
  • potential study participants for pregnancy, significant medical conditions, abnormal laboratory baseline values, unstable psychiatric features(eg.suicidal), history of alcohol of drug dependence, seizures, head trauma with loss of consciousness, neurological illness, or concomitant Axis I psychiatric disorder.

Key Trial Info

Start Date :

February 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2018

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT00817375

Start Date

February 1 2003

End Date

December 1 2018

Last Update

December 31 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Samsung Medical Center

Kangnam, Seoul, South Korea, 135-710

Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients | DecenTrialz